Evidence map›Paper›PMID 39122906›Full record

ArticleAIDS and behavior2024

Gay and Bisexual Men's Perceptions about a Potential HIV Vaccine within a Post-COVID-19 Era: A Qualitative Study.

Alexa B D'Angelo, Michelle H Dearolf, Jennifer MacMartin, Mathew Elder, Denis Nash, Sarit A Golub, Christian Grov

Abstract read
In one paragraph

Article in AIDS and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexa B D'AngeloDepartment of Community Health and Social Sciences, City University of New York (CUNY), Graduate School of Public Health and Health Policy, New York, NY, USA.
Michelle H DearolfDepartment of Community Health and Social Sciences, City University of New York (CUNY), Graduate School of Public Health and Health Policy, New York, NY, USA.
Jennifer MacMartinDepartment of Community Health and Social Sciences, City University of New York (CUNY), Graduate School of Public Health and Health Policy, New York, NY, USA.
Mathew ElderDepartment of Community Health and Social Sciences, City University of New York (CUNY), Graduate School of Public Health and Health Policy, New York, NY, USA.
Denis NashCUNY Institute for Implementation Science in Population Health (ISPH), New York, NY, USA.
Sarit A GolubDepartment of Psychology, Hunter College of CUNY, New York, NY, USA.
Christian GrovDepartment of Community Health and Social Sciences, City University of New York (CUNY), Graduate School of Public Health and Health Policy, New York, NY, USA. Christian.Grov@sph.cuny.edu.ORCID http://orcid.org/0000-0001-6871-3531

Funding

Patient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Vinayaka R. Prasad · 2017 to 2026
$28.3M
Following a U.S. National Cohort of Vulnerable Men to Improve HIV Prevention and CareUH3AI133675 · NIAID · GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY · PI GROV, CHRISTIAN · 2019 to 2021
$6.9M
Following a U.S. National Cohort of Vulnerable Men to Improve HIV Prevention and CareUG3AI133675 · NIAID · GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY · PI GROV, CHRISTIAN · 2017 to 2018
$2.6M
Einstein-Rockefeller-CUNY Center for AIDS Research, Albert Einstein College of Medicine ERC CFAR, P30 AI124414National Institues for Health UH3 AI 133675NIAID NIH HHS P30 AI124414NIAID NIH HHS UG3 AI133675NIAID NIH HHS UH3 AI133675
6 · The paper itself

Abstract

To end the HIV epidemic, there is need for targeted strategies to reduce HIV incidence for those most vulnerable, including an HIV vaccine. This study seeks to understand the perceptions that non-PrEP using gay and bisexual men and other men who have sex with men (GBMSM) have about a potential HIV vaccine, while contextualizing their perspectives within the context of heightened vaccine hesitancy that has emerged since the COVID-19 pandemic. Between March and May of 2022, GBMSM (N = 20) participated in in-depth interviews, which assessed their perceptions about an HIV vaccine. Interviews were analysed using a codebook approach to thematic analysis. We oversampled for those unvaccinated against COVID-19 as a proxy for vaccine hesitation. Participants expressed a range of enthusiastic support, cautious optimism and skepticism when presented with the possibility of an HIV vaccine. Factors that drove willingness to receive an HIV vaccine included community-oriented altruism, individualized risk-benefit assessment, and/or the perception that a vaccine could provide a beneficial shift in sexual experiences. Participants also expressed hesitations about receiving an HIV vaccine, including concerns about potential side-effects and efficacy, as well as mistrust in the vaccine development process. Notably, participants often evaluated the vaccine in comparison to PrEP and condoms. Participants offered specific insights into information they would like to receive about an HIV and where/how they would like to receive it. Our findings can help inform future HIV vaccine implementation efforts by offering insights into the factors that motivate and deter GBMSM to receive an HIV vaccine.

Indexed as

AIDS VaccinesCOVID-19HIV InfectionsHomosexuality, MaleQualitative ResearchSARS-CoV-2AdultBisexualityHealth Knowledge, Attitudes, PracticeHumansInterviews as TopicMaleMiddle AgedPatient Acceptance of Health CareSexual and Gender MinoritiesSexual BehaviorAIDS VaccinesCOVID-19Gay and bisexual menHIV preventionVaccines

Identifiers

PMID39122906
PMCPMC12990139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.